Health technology company Medopad has a successful round of funding for its project that hopes to use big data to manage chroni diseases, reports Venture Beat. 

Medopad, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic diseases, has raised $25 million in a series B round of funding led by Leaps by Bayer, the VC arm of German pharmaceutical giant Bayer, with participation from NWS Holdings and Healthbox, among other investors.